Motley Fool Wealth Management, LLC Ionis Pharmaceuticals Inc Transaction History

Motley Fool Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$59.06 - $72.15 $33.5 Million - $40.9 Million	-567,005 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $2.56 Million - $3.55 Million	-41,207 Reduced 6.78%	567,005 $36.4 Million
Q1 2019 May 07, 2019	BUY	$52.92 - $81.17 $3.87 Million - $5.94 Million	73,125 Added 13.67%	608,212 $49.4 Million
Q4 2018 Feb 12, 2019	SELL	$43.37 - $59.54 $68,654 - $94,251	-1,583 Reduced 0.29%	535,087 $28.9 Million
Q3 2018 Nov 06, 2018	BUY	$42.88 - $53.7 $58,917 - $73,783	1,374 Added 0.26%	536,670 $27.7 Million
Q2 2018 Aug 10, 2018	BUY	$40.53 - $50.7 $8.36 Million - $10.5 Million	206,322 Added 62.72%	535,296 $22.3 Million
Q1 2018 May 04, 2018	SELL	$44.08 - $55.05 $15,604 - $19,487	-354 Reduced 0.11%	328,974 $14.5 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $134,753 - $172,500	-2,679 Reduced 0.81%	329,328 $16.6 Million
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $15.1 Million - $19.8 Million	332,007	332,007 $16.8 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Motley Fool Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Motley Fool Wealth Management, LLC with notifications on news.